Using circulating tumor DNA to identify patients at risk for urothelial cancer relapse after surgical resection could help improve post-surgery treatment, according to a new study.
Enhancing the anti-cancer function of natural killer cells with nanoparticles could unlock their therapeutic potential, according to a Northwestern Medicine study.
A combination therapy pairing a small molecule inhibitor with monoclonal antibody immunotherapy improved patient outcomes for relapsed chronic lymphocytic leukemia, according to a Northwestern Medicine clinical trial.
A novel therapy developed by Northwestern Medicine investigators improved progression-free and overall survival for patients with newly diagnosed malignant gliomas, the most common primary brain tumors in adults.
A targeted virtual health intervention was effective in reducing fear of recurrence among breast cancer survivors.
Using universal myeloid progenitor cells or modified umbilical cord blood may help prevent infections in patients with leukemia, according to a pair of recent studies.
A Northwestern Medicine study has found that women with hormone receptor-positive breast cancer were more likely to discontinue hormone therapy early due to poor quality of life-related outcomes.
A drug currently used to prevent organ rejection in transplants could also reduce chemotherapy resistance in glioblastoma, according to a Northwestern Medicine study.
Northwestern Medicine scientists have described a method of reconstructing the three-dimensional structure of chromosomes in cancer cells and matching those chromosomes with counterpart oncogenes.